Doctor Narek Tmoyan
National Medical Research Center of Cardiology, Moscow (Russian Federation)
Elevated lipoprotein(a) level predicts repeated peripheral revascularization
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session: Peripheral Vascular and Cerebrovascular Disease ePosters
Role of lipoprotein(a) and its autoantibodies in polyvascular atherosclerotic disease
Event: ESC Congress 2020
Topic: Biomarkers
Session: Risk Factors and Prevention ePosters
Obesity paradox, hyperlipoproteinemia(a), autotaxin concentration and stenotic atherosclerosis of different vascular territories
Event: ESC Congress 2019
Topic: Obesity
Session: Obesity
Lipoprotein(a) and clinical outcomes in patients after revascularization of peripheral arteries
Event: ESC Congress 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Advances in peripheral arterial disease
Elevated lipoprotein(a) as a predictor of peripheral artery diseases
Event: ESC Congress 2018
Topic: Lipids, Other
Session: Preventive cardiology / Lipids
Lipoprotein(a) is a marker of peripheral artery disease in the absence of coronary heart disease.
Event: ESC Congress 2017
Topic: Pathophysiology, epidemiology
Session: Vascular diseases
ESC 365 is supported by
